The Turkish Journal of Pediatrics
2013 , Vol 55 , Num 5
Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey
1Division of Neonatology, Department of Pediatrics, McMaster University Hamilton, and 2Medical Outcomes and Research
in Economics (MORE®), Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada.
E-mail: krista.lanctot@sunnybrook.ca
Keywords :
respiratory syncytial virus, prematurity,
palivizumab, prophylaxis.